Latest U.S. Food and Drug Administration News
Selling weight-loss and muscle-building supplements to minors in New York is now illegal
ALBANY, N.Y. (AP) — It’s now illegal to sell weight-loss and muscle-building supplements to minors in New York, under a first-in-the-nation law that went into effect this week. Experts say loose federal regulation of dietary supplements has resulted in these products sometimes...
Remnants of bird flu virus found in pasteurized milk, FDA says
The U.S. Food and Drug Administration said Tuesday that samples of pasteurized milk had tested positive for remnants of the bird flu virus that has infected dairy cows. The agency stressed that the material is inactivated and that the findings “do not represent actual virus that...
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage. Doctors also expect some patients will hesitate to take Leqembi due to...
Company that made millions of defective sleep apnea machines ordered to overhaul manufacturing
WASHINGTON (AP) — The company responsible for a global recall of sleep apnea machines will be barred from resuming production at U.S. facilities until it meets a number of safety requirements, under a long-awaited settlement announced Tuesday by federal officials. Philips will be...
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? In a new study, researchers found that most cancer drugs granted accelerated...
ALS drug will be pulled from US market after study showed patients didn't benefit
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition. Amylyx Pharmaceuticals announced it will...
Lawsuit seeks to force ban on menthol cigarettes after months of delays by Biden administration
WASHINGTON (AP) — Anti-smoking groups sued the U.S. government Tuesday over a long-awaited ban on menthol cigarettes, which has been idling at the White House for months. The lawsuit is the latest effort to force the government to ban menthols, which are disproportionately used by...
Supreme Court again confronts the issue of abortion, this time over access to widely used medication
WASHINGTON (AP) — The Supreme Court will again wade into the fractious issue of abortion this week when it hears arguments over a medication used in the most common way to end a pregnancy, a case with profound implications for millions of women no matter where they live in America and, perhaps,...
Mifepristone access is coming before the US Supreme Court. How safe is this abortion pill?
The U.S. Supreme Court will take up a case Tuesday that could impact how women get access to mifepristone, one of the two pills used in the most common type of abortion in the nation. The central dispute in the case is whether the Food and Drug Administration overlooked serious...
A blood test for colon cancer performed well in a study, expanding options for screening
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths. The test looks for DNA fragments shed by tumor cells and precancerous growths. It's already for sale in the U.S. for $895, but has not...